Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB for Dermatitis atopic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 180 adverse event reports in the FDA FAERS database where NEMOLIZUMAB was used for Dermatitis atopic.

Most Reported Side Effects for NEMOLIZUMAB

Side Effect Reports % Deaths Hosp.
Pemphigoid 51 13.8% 0 16
Death 33 8.9% 33 1
Erythema 26 7.0% 1 12
Dermatitis exfoliative generalised 25 6.7% 0 6
Erythema multiforme 25 6.7% 0 0
Dermatitis atopic 23 6.2% 0 9
Pneumonia 14 3.8% 1 9
Blister 12 3.2% 0 4
Cellulitis 12 3.2% 1 12
Eczema herpeticum 12 3.2% 0 2
Intentional product use issue 10 2.7% 1 1
Pyrexia 10 2.7% 1 6
Rash 10 2.7% 0 6
Neurodermatitis 9 2.4% 0 3
Cardiac failure 7 1.9% 4 3

Other Indications for NEMOLIZUMAB

Neurodermatitis (160) Product used for unknown indication (25) Pruritus (5)

Other Drugs Used for Dermatitis atopic

DUPILUMAB (179,563) UPADACITINIB (5,263) TRALOKINUMAB-LDRM (3,007) CRISABOROLE (2,139) ABROCITINIB (1,616) NEMOLIZUMAB-ILTO (1,596) RUXOLITINIB (740) TACROLIMUS (515) METHOTREXATE (400) CYCLOSPORINE (370)

Related Pages

NEMOLIZUMAB Full Profile All Dermatitis atopic Drugs NEMOLIZUMAB Demographics NEMOLIZUMAB Timeline